CVRx, Inc. Financing Cash Flow
CVRx, Inc. (CVRX) reported Financing Cash Flow of $10.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- CVRx, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.22M, a 211.48% increase year-over-year.
- CVRx, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $8.88M, a 7.62% decline year-over-year.
- CVRx, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $410.00K, a 97.04% decline year-over-year.
- CVRx, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $103.00K, a 99.74% decline year-over-year.
- CVRx, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $10.52M, a 81.17% decline from fiscal 2024.
- CVRx, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $55.87M, a 132.95% increase from fiscal 2023.
- CVRx, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $23.98M, a 220.09% increase from fiscal 2022.
- CVRx, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $7.49M, a 93.30% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.10M 10-Q · filed 2026-08-06 | $10.51M derived: sum of 3 quarters · filed 2026-08-06 | $10.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $8.88M 10-Q · filed 2026-05-12 | $9.29M derived: sum of 2 quarters · filed 2026-05-12 | $9.39M derived: sum of 3 quarters · filed 2026-05-12 | $9.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $513.00K derived: sum of 2 quarters · filed 2026-02-13 | $905.00K derived: sum of 3 quarters · filed 2026-08-06 | $10.52M 10-K · filed 2026-02-13 |
| 2025-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $495.00K derived: sum of 2 quarters · filed 2026-08-06 | $10.11M 10-Q · filed 2025-11-06 | $23.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.01M 10-Q · filed 2026-08-06 | $23.84M derived: sum of 3 quarters · filed 2026-08-06 | $64.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.62M 10-Q · filed 2026-05-12 | $23.45M derived: sum of 2 quarters · filed 2026-05-12 | $63.65M derived: sum of 3 quarters · filed 2026-05-12 | $64.12M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $13.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $54.04M derived: sum of 2 quarters · filed 2026-02-13 | $54.51M derived: sum of 3 quarters · filed 2026-02-13 | $55.87M 10-K · filed 2026-02-13 |
| 2024-09-30 | $40.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $40.67M derived: sum of 2 quarters · filed 2025-11-06 | $42.04M 10-Q · filed 2025-11-06 | $57.62M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.83M 10-Q · filed 2025-08-05 | $17.41M derived: sum of 3 quarters · filed 2025-08-05 | $17.78M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.36M 10-Q · filed 2025-05-09 | $16.94M derived: sum of 2 quarters · filed 2025-05-09 | $17.30M derived: sum of 3 quarters · filed 2025-05-09 | $17.78M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $15.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $15.94M derived: sum of 2 quarters · filed 2025-02-18 | $16.42M derived: sum of 3 quarters · filed 2025-02-18 | $23.98M 10-K · filed 2025-02-18 |
| 2023-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $836.00K derived: sum of 2 quarters · filed 2024-11-01 | $8.40M 10-Q · filed 2024-11-01 | $15.52M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $473.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $8.04M 10-Q · filed 2024-08-02 | $15.16M derived: sum of 3 quarters · filed 2024-08-02 | $15.16M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $7.57M 10-Q · filed 2024-05-10 | $14.69M derived: sum of 2 quarters · filed 2024-05-10 | $14.69M derived: sum of 3 quarters · filed 2024-05-10 | $15.01M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $7.12M derived: sum of 2 quarters · filed 2024-02-09 | $7.45M derived: sum of 3 quarters · filed 2024-02-09 | $7.49M 10-K · filed 2024-02-09 |
| 2022-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $328.00K derived: sum of 2 quarters · filed 2023-10-31 | $376.00K 10-Q · filed 2023-10-31 | -$20.91M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $369.00K 10-Q · filed 2023-08-03 | -$20.92M derived: sum of 3 quarters · filed 2023-08-03 | $112.25M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $48.00K 10-Q · filed 2023-05-11 | -$21.24M derived: sum of 2 quarters · filed 2023-05-11 | $111.93M derived: sum of 3 quarters · filed 2023-05-11 | $111.93M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$21.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $111.88M derived: sum of 2 quarters · filed 2023-02-10 | $111.88M derived: sum of 3 quarters · filed 2023-02-10 | $111.88M 10-K · filed 2023-02-10 |
| 2021-09-30 | $133.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $133.17M derived: sum of 2 quarters · filed 2022-11-04 | $133.17M 10-Q · filed 2022-11-04 | $133.17M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $2.00K 10-Q · filed 2022-08-01 | $2.00K derived: sum of 3 quarters · filed 2022-08-01 | $49.78M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-02 | $2.00K derived: sum of 2 quarters · filed 2022-05-02 | $49.78M derived: sum of 3 quarters · filed 2022-05-02 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $49.78M derived: sum of 2 quarters · filed 2022-02-22 | $49.78M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $49.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $49.78M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |